A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study, to Investigate the Safety, Tolerability, PK and PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects

Trial Profile

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study, to Investigate the Safety, Tolerability, PK and PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jun 2014

At a glance

  • Drugs Tegoprazan (Primary) ; Esomeprazole
  • Indications Erosive oesophagitis; Gastro-oesophageal reflux; Peptic ulcer
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors CJ Cheiljedang Corp.
  • Most Recent Events

    • 22 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top